2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity
- 1 November 2023
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 325 (5) , E425-E437
Abstract
Walter Cannon was a highly regarded American neurologist and physiologist with extremely broad interests. In the tradition of Cannon and his broad interests, we discuss our laboratory’s multifaceted work in signal transduction over the past 40+ years. We show how our questioning of how growth hormone (GH) in the blood communicates with cells throughout the body to promote body growth and regulate body metabolism led to insight into not only body height but also important regulators of malignancy and body weight. Highlights include finding that 1) A critical initiating step in GH signal transduction is GH activating the GH receptor-associated tyrosine kinase JAK2; 2) GH activation of JAK2 leads to activation of a number of signaling proteins, including STAT transcription factors; 3) JAK2 is autophosphorylated on multiple tyrosines that regulate the activity of JAK2 and recruit signaling proteins to GH/GH receptor/JAK2 complexes; 4) Constitutively activated STAT proteins are associated with cancer; 5) GH activation of JAK2 recruits the adapter protein SH2B1 to GH/GH receptor/JAK2 complexes where it facilitates GH regulation of the actin cytoskeleton and motility; and 6) SH2B1 is recruited to other receptors in the brain, where it enhances satiety, most likely in part by regulating leptin action and neuronal connections of appetite-regulating neurons. These findings have led to increased understanding of how GH functions, as well as therapeutic interventions for certain cancer and obese individuals, thereby reinforcing the great importance of supporting basic research since one never knows ahead of time what important insight it can provide.Keywords
Funding Information
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (R01-DK-054222)
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (R01-DK-017730)
This publication has 102 references indexed in Scilit:
- Human SH2B1 mutations are associated with maladaptive behaviors and obesityJournal of Clinical Investigation, 2012
- Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in HumansScience Translational Medicine, 2011
- Large, rare chromosomal deletions associated with severe early-onset obesityNature, 2009
- Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617FJournal of Leukocyte Biology, 2009
- Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2Journal of Clinical Investigation, 2008
- Adapter Protein SH2-Bβ Stimulates Actin-Based Motility of Listeria monocytogenes in a Vasodilator-Stimulated Phosphoprotein (VASP)-Dependent FashionInfection and Immunity, 2007
- Neuronal SH2B1 is essential for controlling energy and glucose homeostasisJournal of Clinical Investigation, 2007
- Binding of SH2-B Family Members within a Potential Negative Regulatory Region Maintains JAK2 in an Active StateMolecular and Cellular Biology, 2006
- Human growth hormone doping in sportBritish Journal of Sports Medicine, 2006
- Phosphorylation of JAK2 at Serine 523: a Negative Regulator of JAK2 That Is Stimulated by GrowthHormone and Epidermal Growth FactorMolecular and Cellular Biology, 2006